PTC vs VIR · P/E 48, rev $2.74B vs rev $74.2M
PTC Inc (PTC) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
PTC Inc (PTC) is a software - application company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
PTC currently screens at market cap $21.11B and trailing P/E 48.3. VIR currently screens at market cap $1.45B.
Not investment advice. Open the PTC and VIR stock pages for the full models.
Not investment advice.